Rictor/torc2 regulates Caenorhabditis elegans fat storage, body size, and development through sgk-1

PLoS Biology

Volumn 7, Issue 3, 2009, Pages 0604-0615

  Jones, Kevin T ^a   Greer, Elisabeth R ^a   Pearce, David ^b   Ashrafi, Kaveh ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE B; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; TARGET OF RAPAMYCIN KINASE; AKT 1 PROTEIN, C ELEGANS; AKT-1 PROTEIN, C ELEGANS; CAENORHABDITIS ELEGANS PROTEIN; CARRIER PROTEIN; PROTEIN SERINE THREONINE KINASE; RICTOR PROTEIN, C ELEGANS; SGK 1 PROTEIN, C ELEGANS; SGK-1 PROTEIN, C ELEGANS;

ANIMAL EXPERIMENT; ARTICLE; BODY SIZE; CAENORHABDITIS ELEGANS; GENE; LIPID STORAGE; NONHUMAN; PHYSICAL DEVELOPMENT; PROTEIN PHOSPHORYLATION; RICTOR GENE; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; LIPID METABOLISM; METABOLISM; MUTATION;

ANIMALIA; CAENORHABDITIS ELEGANS; MAMMALIA;

ANIMALS; BODY SIZE; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; CARRIER PROTEINS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; LIPID METABOLISM; MUTATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 65949103405     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.1000060     Document Type: Article

References (54)

1. Wullschleger S, Loewith R, Hall MN (2006) TOR signaling in growth and metabolism. Cell 124: 471-484.
2. Tsang CK, Qi H, Liu LF, Zheng XF (2007) Targeting mammalian target of rapamycin (mTOR) for health and diseases. Drug Discov Today 12: 112-124.
3. Loewith R, Jacinto E, Wullschleger S, Lorberg A, Crespo JL, et al. (2002) Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol Cell 10: 457-468.
4. Hara K, Maruki Y, Long X, Yoshino K, Oshiro N, et al. (2002) Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110: 177-189.
5. Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR, et al. (2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110: 163-175.
6. Price DJ, Grove JR, Calvo V, Avruch J, Bierer BE (1992) Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase. Science 257: 973-977.
7. Chung J, Kuo CJ, Crabtree GR, Blenis J (1992) Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell 69: 1227-1236.
8. Beretta L, Gingras AC, Svitkin YV, Hall MN, Sonenberg N (1996) Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap- dependent initiation of translation. EMBO J 15: 658-664.
9. Heitman J, Movva NR, Hall MN (1991) Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science 253: 905-909.
10. Bentzinger CF, Romanino K, Cloetta D, Lin S, Mascarenhas JB, et al. (2008) Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab 8: 411-424.
11. Polak P, Cybulski N, Feige JN, Auwerx J, Ruegg MA, et al. (2008) Adipose- specific knockout of raptor results in lean mice with enhanced mitochon- drial respiration. Cell Metab 8: 399-410.
12. Kumar A, Harris TE, Keller SR, Choi KM, Magnuson MA, et al. (2008) Muscle-specific deletion of rictor impairs insulin-stimulated glucose trans- port and enhances Basal glycogen synthase activity. Mol Cell Biol 28: 61-70.
13. Shiota C, Woo JT, Lindner J, Shelton KD, Magnuson MA (2006) Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability. Dev Cell 11: 583-589.
14. Guertin DA, Stevens DM, Thoreen CC, Burds AA, Kalaany NY, et al. (2006) Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev Cell 11: 859-871.
15. Chen MY, Long Y, Devreotes PN (1997) A novel cytosolic regulator, Pianissimo, is required for chemoattractant receptor and G protein- mediated activation of the 12 transmembrane domain adenylyl cyclase in Dictyostelium. Genes Dev 11: 3218-3231.
16. Hietakangas V, Cohen SM (2007) Re-evaluating AKT regulation: role of TOR complex 2 in tissue growth. Genes Dev 21: 632-637.
17. Lee G, Chung J (2007) Discrete functions of rictor and raptor in cell growth regulation in Drosophila. Biochem Biophys Res Commun 357: 1154-1159.
18. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM (2005) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307: 1098-1101.
19. Carnero A, Blanco-Aparicio C, Renner O, Link W, Leal JF (2008) The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets 8: 187-198.
20. Ikenoue T, Inoki K, Yang Q, Zhou X, Guan KL (2008) Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling. EMBO J 27: 1919-1931.
21. Facchinetti V, Ouyang W, Wei H, Soto N, Lazorchak A, et al. (2008) The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C. EMBO J 27: 1932-1943.
22. Jacinto E, Facchinetti V, Liu D, Soto N, Wei S, et al. (2006) SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphor- ylation and substrate specificity. Cell 127: 125-137.
23. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, et al. (1996) Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 15: 6541-6551.
24. Aronova S, Wedaman K, Aronov PA, Fontes K, Ramos K, et al. (2008) Regulation of ceramide biosynthesis by TOR complex 2. Cell Metab 7: 148-158.
25. Kamada Y, Fujioka Y, Suzuki NN, Inagaki F, Wullschleger S, et al. (2005) Tor2 directly phosphorylates the AGC kinase Ypk2 to regulate actin polarization. Mol Cell Biol 25: 7239-7248.
26. Jacinto E, Loewith R, Schmidt A, Lin S, Ruegg MA, et al. (2004) Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat Cell Biol 6: 1122-1128.
27. Ashrafi K, Chang FY, Watts JL, Fraser AG, Kamath RS, et al. (2003) Genome- wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature 421: 268-272.
28. Ho HL, Shiau YS, Chen MY (2005) Saccharomyces cerevisiaeTSC11/AVO3 participates in regulating cell integrity and functionally interacts with components of the Tor2 complex. Curr Genet 47: 273-288.
29. Mak HY, Nelson LS, Basson M, Johnson CD, Ruvkun G (2006) Polygenic control of Caenorhabditis elegans fat storage. Nat Genet 38: 363-368.
30. McKay RM, McKay JP, Avery L, Graff JM (2003) C elegans: a model for exploring the genetics of fat storage. Dev Cell 4: 131-142.
31. Long X, Spycher C, Han ZS, Rose AM, Muller F, et al. (2002) TOR deficiency in C. elegans causes developmental arrest and intestinal atrophy by inhibition of mRNA translation. Curr Biol 12: 1448-1461.
32. Jia K, Chen D, Riddle DL (2004) The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span. Development 131: 3897-3906.
33. Suzuki Y, Yandell MD, Roy PJ, Krishna S, Savage-Dunn C, et al. (1999) A BMP homolog acts as a dose-dependent regulator of body size and male tail patterning in Caenorhabditis elegans. Development 126: 241-250.
34. Daniels SA, Ailion M, Thomas JH, Sengupta P (2000) egl-4 acts through a transforming growth factor-beta/SMAD pathway in Caenorhabditis elegans to regulate multiple neuronal circuits in response to sensory cues. Genetics 156: 123-141.
35. Fujiwara M, Sengupta P, McIntire SL (2002) Regulation of body size and behavioral state of C. elegans by sensory perception and the EGL-4 cGMP- dependent protein kinase. Neuron 36: 1091-1102.
36. Raizen DM, Cullison KM, Pack AI, Sundaram MV (2006) A novel gain-of- function mutant of the cyclic GMP-dependent protein kinase egl-4 affects multiple physiological processes in Caenorhabditis elegans. Genetics 173: 177-187.
37. Yoshida S, Morita K, Mochii M, Ueno N (2001) Hypodermal expression of Caenorhabditis elegans TGF-beta type I receptor SMA-6 is essential for the growth and maintenance of body length. Dev Biol 240: 32-45.
38. Krishna S, Maduzia LL, Padgett RW (1999) Specificity of TGFbeta signaling is conferred by distinct type I receptors and their associated SMAD proteins in Caenorhabditis elegans. Development 126: 251-260.
39. Maduzia LL, Gumienny TL, Zimmerman CM, Wang H, Shetgiri P, et al. (2002) lon-1 regulates Caenorhabditis elegans body size downstream of the dbl-1 TGF beta signaling pathway. Dev Biol 246: 418-428.
40. Morita K, Flemming AJ, Sugihara Y, Mochii M, Suzuki Y, et al. (2002) A Caenorhabditis elegans TGF-beta, DBL-1, controls the expression of LON- 1, a PR-related protein, that regulates polyploidization and body length. EMBO J 21: 1063-1073.
41. Avery L (1993) The genetics of feeding in Caenorhabditis elegans. Genetics 133: 897-917.
42. Sale EM, Sale GJ (2008) Protein kinase B: signalling roles and therapeutic targeting. Cell Mol Life Sci 65: 113-127.
43. Paradis S, Ruvkun G (1998) Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor. Genes Dev 12: 2488-2498.
44. Hertweck M, Gobel C, Baumeister R (2004) C. elegans SGK-1 is the critical component in the Akt/PKB kinase complex to control stress response and life span. Dev Cell 6: 577-588.
45. Lee S, Comer FI, Sasaki A, McLeod IX, Duong Y, et al. (2005) TOR complex 2 integrates cell movement during chemotaxis and signal relay in Dictyostelium. Mol Biol Cell 16: 4572-4583.
46. Garcia-Martinez JM, Alessi DR (2008) mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem J 416: 375-385.
47. McCormick JA, Feng Y, Dawson K, Behne MJ, Yu B, et al. (2004) Targeted disruption of the protein kinase SGK3/CISK impairs postnatal hair follicle development. Mol Biol Cell 15: 4278-4288.
48. Wulff P, Vallon V, Huang DY, Volkl H, Yu F, et al. (2002) Impaired renal Na(&Thorn) retention in the sgk1-knockout mouse. J Clin Invest 110: 1263-1268.
49. Brenner S (1974) The genetics of Caenorhabditis elegans. Genetics 77: 71-94.
50. Srinivasan S, Sadegh L, Elle IC, Christensen AG, Faergeman NJ, et al. (2008) Serotonin regulates C. elegans fat and feeding through independent molecular mechanisms. Cell Metab 7: 533-544.
51. Husson SJ, Janssen T, Baggerman G, Bogert B, Kahn-Kirby AH, et al. (2007) Impaired processing of FLP and NLP peptides in carboxypeptidase E (EGL- 21)-deficient Caenorhabditis elegans as analyzed by mass spectrometry. J Neurochem 102: 246-260.
52. Timmons L, Fire A (1998) Specific interference by ingested dsRNA. Nature 395: 854.
53. Kamath RS, Fraser AG, Dong Y, Poulin G, Durbin R, et al. (2003) Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature 421: 231-237.
54. Rual JF, Ceron J, Koreth J, Hao T, Nicot AS, et al. (2004) Toward improving Caenorhabditis elegans phenome mapping with an ORFeome-based RNAi library. Genome Res 14: 2162-2168.